Articles

Podcasts

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

As the number of entecavir manufacturers increased from 1-11, the NADAC decreased from $30.12 to $1.93 per 0.5 mg tablet. 

Out-of-Pocket Spending Remains High for Chronic Hepatitis B Treatments

There are several barriers that prevent better HCV care, including availability and access to diagnostic and monitoring tests and the requirement for frequent medical visits during treatment.

MINMON Approach Could Boost Hepatitis C Treatment Adherence 

Exposure to long-term prescription opioid therapy was linked to a 3.2-fold higher risk of HCV seroconversion compared to individuals who were prescription opioid-naïve or acute. 

Long-Term Prescription Opioid Use Linked to Higher Risk of Hepatitis C

Weight loss could be beneficial for NASH and NAFLD patients.

A. Sidney Barritt, MD: What's Next for TARGET-NASH

TARGET-NASH as now expanded into European centers.

A. Sidney Barritt, MD: An Update on TARGET-NASH

The US recommended HBV vaccines to be part of the infant immunization plan in 1991. 

Infant Hepatitis B Vaccination Program Reducing Mortality Rate 

The rigidity of hospital settings and a lack of awareness prevents better hepatitis C virus diagnoses in the homeless population.

Multiple Barriers Prevent Better HCV Care for Homeless Population

The recombinant vaccine resulted in higher rates of seroprotection in all subjects, particularly those 45 years and older. 

FDA Approves 3-Antigen Hepatitis B Vaccine

Only 5 individuals of 195 who received liver transplantation had HCC reoccur more than 3 years following surgery. 

HCC Reoccurs in 1 of 7 Following Liver Transplantation

Various factors decreased the likelihood of achieving SVR, including male gender, cirrhosis, recent injecting drug use, and previous DAA treatment.

Access to Direct-Acting Antivirals Improves Outcomes for Hepatitis C Patients

Hepatitis C page, resources on the topics of medical news and expert insight into HCV can be found. Content includes articles, interviews, videos, podcasts, and breaking news on hepatitis C virus research, treatment, and drug development.